SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-22-010514
Filing Date
2022-07-01
Accepted
2022-07-01 16:11:23
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20220701xs3.htm S-3 559960
2 EX-1.2 tmb-20220701xex1d2.htm EX-1.2 322185
3 EX-4.3 tmb-20220701xex4d3.htm EX-4.3 38769
4 EX-4.4 tmb-20220701xex4d4.htm EX-4.4 419099
5 EX-5.1 tmb-20220701xex5d1.htm EX-5.1 45226
6 EX-23.1 tmb-20220701xex23d1.htm EX-23.1 3803
7 EX-FILING FEES tmb-20220701xexfilingfees.htm EX-FILING FEES 29552
8 GRAPHIC tmb-20220701xs3008.jpg GRAPHIC 8736
9 GRAPHIC tmb-20220701xex5d1001.jpg GRAPHIC 11769
  Complete submission text file 0001558370-22-010514.txt   1448240
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265979 | Film No.: 221061492
SIC: 2836 Biological Products, (No Diagnostic Substances)